Indaptus Therapeutics
INDP
INDP
30 hedge funds and large institutions have $90.1M invested in Indaptus Therapeutics in 2018 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 2 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
85% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 13
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
30
Holding in Top 10
–
Calls
$313K
Puts
$76K
Top Buyers
| 1 | +$2.97M | |
| 2 | +$890K | |
| 3 | +$398K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$344K |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$336K |
Top Sellers
| 1 | -$4.98M | |
| 2 | -$2.45M | |
| 3 | -$607K | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$557K |
| 5 |
ACA
Avoro Capital Advisors
New York
|
-$541K |